藥劑部首頁

電子處方集
處方集PDA版
中西藥交互作用查詢
健保給付規定
不良反應通報系統
意見信箱
 Urokinase   仿單連結                                     

點小圖看大圖

 14U035,25萬IU/Vial更動後

中文名:血栓溶素注射劑

廠牌:綠十字

點小圖看大圖

 14U035,25萬IU/Vial更動前

中文名:

廠牌:

Product name
 Urokinase
Dosage form
 14U035, 25萬IU/Vial
Indications
Pulmonary embolism
Administration & Dosage

IV,
Pulmonary embolism: IV, initial 4400 IU/kg> 10 min, followed by 4400 IU/kg/hr for 12 hrs.

Contraindication

hypersensitivity to urokinase;
active internal bleeding;
severe uncontrolled hypertension;
recent intracranial or intraspinal surgery or trauma;
intracranial neoplasm, arteriovenous malformation, or aneurysm;
known bleeding diathesis; history of cerebrovascular accident

Precaution
 
Adverse reaction
Decreased hematocrit; anaphylaxis; infusion reaction; reperfusion ventricular; arrhythmias; vascular embolization; significant bleeding 
Drug Interaction
 
Pregnancy Category
B
Notes
Heparin should be discontinued during the IV administration of urokinase 
最近更新日期 2015年9月24日